Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00595491 · ClinicalTrials.gov registry record · Phase 1
Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation
A Phase 1 study of Asthma, sponsored by Benjamin Medoff.
- Recruiting
- Registry status
- Phase 1
- Development phase
- 313
- Enrollment target
- 1
- Study location
NCT00595491 is a Phase 1 study of Asthma that is actively recruiting participants, run by Benjamin Medoff. The registered enrollment target is 313 participants, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state.
The verdict
NCT00595491, a Phase 1 study of Asthma, is actively recruiting participants, sponsored by Benjamin Medoff.
- RECRUITING
- Registry status
- Phase 1
- Development phase
- 313 participants
- Enrollment target
- 1
- Study location
Study Summary
Asthma is a heterogeneous disorder in which multiple potential inflammatory pathways contribute to airway obstruction. The biological basis for airway inflammation is the subject of intensive investigation. This work is designed to identify airway factors that are responsible for recruiting cells and associate their airway presence with atopy and asthma.
Conditions Studied
Interventions
- BIOLOGICAL Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 313 participants |
| Start Date | 2008-01 |
| Est. Completion | 2029-01-31 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00595491
The ClinicalTrials.gov registry entry for NCT00595491 describes a study currently listed as recruiting, categorized as Phase 1. The registered enrollment target is 313 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,563-participant average among 374 other Asthma trials with a reported enrollment target (80% lower). The listed sponsor is Benjamin Medoff, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Asthma appearing as the primary indexed condition, and to 1 intervention - of which Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage is the first listed.
NCT00595491 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT00595491 about?
NCT00595491 is a clinical study titled "Pilot Study to Identify the Mediators and Inflammatory Cell Surface Receptors Involved in Allergic Airway Inflammation". Asthma is a heterogeneous disorder in which multiple potential inflammatory pathways contribute to airway obstruction. The biological basis for airway inflammation is the subject of intensive investigation. This work is designed to identify airway factors that are responsible for recruiting cells an...
What is the current status of trial NCT00595491?
This trial is currently recruiting. It is a Phase 1 study. The enrollment target is 313 participants. The study started on 2008-01. Estimated completion is 2029-01-31.
What conditions does trial NCT00595491 study?
This clinical trial studies the following conditions: Asthma.
What interventions are being tested in trial NCT00595491?
The interventions under investigation include: Bronchoscopy, Segmental Allergen Challenge, and Broncheoalveolar Lavage (BIOLOGICAL).
Who is sponsoring clinical trial NCT00595491?
This trial is sponsored by Benjamin Medoff, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00595491 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Asthma
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Hyperpolarized 129Xe MR Imaging of Lung Function in Healthy Volunteers and Subjects With Pulmonary Disease
RECRUITING · Phase 1
-
A Study to Investigate How Budesonide and Formoterol Move Through the Body (Pharmacokinetics) When Delivered With Different Devices in Participants Aged 4 to Less Than 12 Years Old With Asthma
RECRUITING · Phase 1
-
A Phase 1, Randomized, Double-blind, Placebo-controlled Study Evaluating AMG 691 in Healthy Participants and Participants With Mild-to-Moderate Asthma
RECRUITING · Phase 1
-
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK), and Immunogenicity of APG777 in Adults With Asthma
ACTIVE NOT RECRUITING · Phase 1
-
A Study to Investigate GB-0895 in Adults With Mild to Moderate Asthma or COPD
ACTIVE NOT RECRUITING · Phase 1
-
Symptom-driven ICS/LABA Therapy for Patients With Asthma Non-adherent to Daily Maintenance Inhalers
ACTIVE NOT RECRUITING · Phase 1
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.